scholarly article | Q13442814 |
P50 | author | Mark B Schapiro | Q114423687 |
James V. Haxby | Q23992770 | ||
Pietro Pietrini | Q25308513 | ||
Cheryl L. Grady | Q26722137 | ||
Charles DeCarli | Q28516591 | ||
P2093 | author name string | Kumar A | |
Ball MJ | |||
Kaye JA | |||
P2860 | cites work | Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years | Q48746854 |
Pathological basis for neurotransmitter changes in Parkinson's disease | Q48857336 | ||
Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. | Q52065251 | ||
Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. | Q52120461 | ||
The morphological basis of dementia in Parkinson's disease. | Q53198121 | ||
Integrated phylogeny of the primate brain, with special reference to humans and their diseases | Q57150906 | ||
TIME COURSE OF EFFECTS OF UNILATERAL LESIONS OF THE NUCLEUS BASALIS OF MEYNERT ON GLUCOSE UTILIZATION BY THE CEREBRAL CORTEX | Q59858948 | ||
Local cerebral glucose utilization following unilateral and bilateral lesions of the nucleus basalis magnocellularis in the rat | Q67948236 | ||
'Normal'-pressure hydrocephalus and the saga of the treatable dementias | Q69323561 | ||
Alternative formula for glucose utilization using labeled deoxyglucose | Q70349069 | ||
“Mini-mental state” | Q25938989 | ||
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex | Q29391304 | ||
The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. | Q34062645 | ||
Cerebral blood flow in dementia | Q34518886 | ||
Primary degenerative dementia without Alzheimer pathology | Q42526180 | ||
Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features | Q43458149 | ||
Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type | Q44534844 | ||
Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra | Q45020106 | ||
Severity of vascular dementia is related to volume of metabolically impaired tissue | Q45238509 | ||
High-resolution PET studies in Alzheimer's disease | Q45738975 | ||
Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type | Q48292484 | ||
Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia | Q48305999 | ||
Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose | Q48619036 | ||
Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method | Q48674190 | ||
Cortical cholinergic deficit in mentally impaired Parkinsonian patients | Q48736820 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Alzheimer's disease | Q11081 |
P304 | page(s) | 859-864 | |
P577 | publication date | 1993-08-01 | |
P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
P1476 | title | Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease | |
P478 | volume | 56 |
Q30784946 | A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile |
Q37756103 | Autopsy as gold standard in FDG-PET studies in dementia. |
Q41012601 | Diagnostic testing and dementia |
Q35891782 | Neuroimaging and cognition in Parkinson's disease dementia. |
Q27691820 | Neuroimaging biomarkers of neurodegenerative diseases and dementia |
Q30756562 | Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology |
Q40940214 | The clinical epidemiology of Alzheimer's disease |
Q72136177 | The metabolic topography of parkinsonism |
Search more.